Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
COVID-19 and Alcohol-associated Liver DiseaseModerated by: Ashwani K. Singal, MD, MS, FACG, FAASLD& Pranoti Mandrekar, PhD, FAASLD
© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Webinar ModeratorsAshwani K. Singal, MD, MS, FACG, FAASLD• Associate Professor of
Medicine, University of South Dakota
• Chair – AASLD Alcohol-associated Liver Disease SIG
Pranoti Mandrekar, PhD, FAASLD• Professor, University of
Massachusetts Medical School
• Chair-Elect – AASLD Alcohol-associated Liver Disease SIG
14© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Webinar Agenda
15© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Talks Speakers
Webinar and Presenter Introductions Drs. Pranoti Mandrekar & Dr. Ashwani Singal
"Alcohol Use During COVID-19: Impact Unknown” Dr. Brenda Curtis
“How is COVID-19 Affecting Alcohol-Associated Liver Disease?” Dr. Andrew Moon
Panel Discussion / Q&A All
Webinar Q&A• Submit your questions anytime during the webinar in the Q&A
box at the top or bottom of your screen.
• Questions will be answered at the end of the presentations.
16© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Webinar PresenterBrenda Curtis, PhD MsPH
• Tenure Track Investigator• Technology and Translational
Research Unit, Chief • Translational Addiction Medicine
Branch, NIDA-IRP
17© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Webinar PresenterAndrew Moon, MD, MPH• Advanced/Transplant Hepatology
Fellow, University of North Carolina
18© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Webinar PanelistElizabeth C. Verna, MD, MSc• Director of Clinical Research,
Columbia University Transplant Initiative and the Transplant Clinical Research Center
• Director of Hepatology Research, Columbia University Division of Digestive and Liver Disease
Oren K. Fix, MD, MSc, FAASLD • Medical Director, Liver
Transplant Program, Swedish Medical Center, Seattle, WA
• Clinical Associate Professor, Washington State University Elson S. Floyd College of Medicine
19© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Alcohol Use During COVID-19: Impact UnknownBrenda Curtis, PhD, MsPHNIDA/IRP Technology and Translational Research UnitTranslational Addiction Medicine Branch
© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Covid 19, Alcohol Consumption & Potential Impacts
• Alcohol Consumption & the Immune System
Susceptibility & Severity
• Stress, Anxiety, & Well-being
Consumption & AUD symptoms
• Social Isolation & Physical Distancing
Consumption & AUD symptoms
• Alcohol-Associated Liver DiseaseHealthcare access & treatment
Covid 19 & Alcohol Consumption• Early epidemiological and marketing data
indicate a spike in use of alcohol and other drugs by the general population.
• Week ending March 21, sales of distilled liquor were 75% greater than during the same week in 2019; beer sales, 66% greater
• Compared with this time a year ago, during the seven-week COVID-impacted period ended April 25,
• brick-and-mortar alcohol dollar sales up 26%
• online sales of alcohol have skyrocketed 477%
Digital Phenotyping, AUD research & COVID-19
24© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG Unpublished. Curtis, Epstein, Leggio, 2020
Specific AimsExamine
Examine effects of the Covid-19 pandemic on drug use, drug-related behaviors, consequences of drug use, in people with and without AUD/SUDs at the start of the study
Investigate
Investigate bidirectional effects between the Covid-19 pandemic and access/adherence to treatment, in people who have or develop AUD/SUDs
Improve
Improve our methodology for the detection of daily-life behavioral markers of:
• movement patterns, weight/diet• social interactions, support, &
distancing• substance use• resilience and wellbeing• psychological problems
Unpublished. Curtis, Epstein, Leggio, 2020
Study Design
BaselineN=2500
Social Media
PHQ-9
Drug Use
GAD-7
COVID
….
30 Days DAY 60
Social Media
PHQ-9
Drug Use
GAD-7
COVID
….
Day 90
Social Media
PHQ-9
Drug Use
GAD-7
COVID…
.
Day 120
Social Media
PHQ-9
Drug Use
GAD-7
COVID
….
Smartphone Sensor StudyN=300
EMA
Unpublished. Curtis, Epstein, Leggio, 2020
Smartphone Sensor Study: Digital Phenotyping
Sensor Data Source Behavior
Physical Movement Social Interactions
Daily Activities
Accelerometer
Bluetooth
GPS
Light sensor
Wi-Fi scans
Phone use logs (call/SMS)
App use logs
Social Media Language*
● N = 568, Mean Age = 35.84, SD = 13.07● 74% White● 62% Bachelor’s degree or higher● 45% under $50k income● Substance use history:
○ 60% Cannabis○ 78% Alcohol○ 30% Opiates○ 12% Cocaine
Preliminary Results - Demographics
Unpublished. Curtis, Epstein, Leggio, 2020
Preliminary Results Experiences During COVID-19
● 4% diagnosed with COVID-19● Concern for themselves (82%) or loved ones (89%) getting
COVID-19● More anxiety (77%) and depression (53%)● Personal financial loss (77%)● Increase in alcohol use (28%)
Unpublished. Curtis, Epstein, Leggio, 2020
Language more frequently used in 2020
Changes in language estimated psychological distress
Language changes in 2020 (vs 2019)
Unpublished. Curtis, Epstein, Leggio, 2020
Physical DistancingData from the UK: (telephone survey 2 months after lockdown, pre-existing AUD patients)
• 20% of individuals increasing or decreasing their normal alcohol consumption
• Decrease probably associated with decrease financial ability and decreased availability of on-site alcohol areas
References
32© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Retail Analytics: Nielsen. https://twitter.com/nielsen/status/1248366074317418498. Accessed Dec 2, 2020.
Rebalancing the ‘Covid-19 Effect’ on Alcohol Sales: Nielsen. https://www.nielsen.com/us/en/insights/article/2020/rebalancing-the-covid-19-effect-on-alcohol-sales/#:~:text=A%20Nielsen%20investigation%20of%20the,of%20closed%20bars%20and%20restaurants. Accessed Dec 2, 2020.
Da, B. L., Im, G. Y., & Schiano, T. D. (2020). COVID-19 hangover: a rising tide of alcohol use disorder and alcohol-associated liver disease. Hepatology, 72(3)), 1102-8.
Micallef JV. How The COVID-19 Pandemic is Upending the Alcoholic Beverage Industry. Forbes. April 4, 2020.
Cotti C, Dunn RA, Tefft N. The Dow is Killing Me: Risky Health Behaviors and the Stock Market. Health Economics 2015;24:803-821.
Black H, Gill J, Chick J. The price of a drink: levels of consumption and price paid per unit of alcohol by Edinburgh's ill drinkers with a comparison to wider alcohol sales in Scotland. Addiction (Abingdon, England) 2011;106:729-736.
References
33© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Kushner, T., & Cafardi, J. (2020). Chronic Liver Disease and COVID-19: Alcohol Use Disorder/Alcohol-Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated Cirrhosis. Clinical Liver Disease, 15(5), 195.
Kim, J. U., Majid, A., Judge, R., Crook, P., Nathwani, R., Selvapatt, N., ... & Lewis, H. (2020). Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder. The Lancet Gastroenterology & Hepatology, 5(10), 886-887.
Alcohol Change UK. Drinking during lockdown: headline findings. https://alcoholchange.org.uk/blog/2020/covid19-drinking-during-lockdown-headline-findings. Accessed Dec 1, 2020
How is COVID-19 Affecting Alcohol-Associated Liver Disease?Andrew M. Moon, MD, MPHAdvanced/Transplant Hepatology FellowUniversity of North Carolina© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
DisclosuresNo potential conflicts of interest to disclose.
My research was supported in part by NIH grant T32 DK007634.
35© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Rising Prevalence and Costs of ALD
37© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Mellinger et al. Hepatology 2018. Hirode et al. JAMA Netw Open 2020.Barritt et al. Dig Dis Sci 2020.
ALD Most Common LT Indication
38© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Lee et al. JAMA Intern Med 2019.
ALD Deaths on the Rise
39© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Moon et al. Am J Gastroenterol 2020.
AAPC (1999-2017)
Women, 25-34 6.07 (2.95-9.28)
Women, 65-74 1.81 (0.92-2.71)
Men, 25-34 4.95(3.21-6.73)
Men, 65-74 1.15(0.31-2.00)
COVID-19 Outcomes in ALD
40© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Effects of Excess Alcohol Use on ALD
43© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Effect of Excess Alcohol Use on ALD
44
Unsafe Alcohol Use
d
d
Binge Drinking
2h
2h
Crabb et al. Hepatology 2019.
Effect of Alcohol Use on Mortality in AH
46© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORGLlouvet et al. Hepatology 2017.
Follow-up:3 mos x 1 year6 mos thereafter
Median Follow-up 42 months
70% mortality in steroid non-responders at 6 mos
Effect of Alcohol Use on Mortality in ALD
47© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Verrill et al. Addiction 2009.
cum
ulat
ive
surv
ival
(%)
Effect of COVID-19 on ALD?
48© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Post-COVID Increase in AH
50
© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG Moon et al. (unpublished data)
Stay at home order
Admissions % ChangeMay-Oct 19 377 -May-Oct 20 505 +34%
De-Listing from Liver Transplant List
51© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Increased risk of relapse in listed
patients
Kim et al. Lancet Gastro & Hep 2020.
Delisting
Conclusions• Prior to COVID-19, alcohol-associated liver disease had a large
and growing burden• COVID-19 outcomes may be worse in ALD patients• Psychosocial strain and limited access to healthcare has likely
led to higher risk alcohol consumption patterns• Increased alcohol use has the potential to significantly increase
morbidity and mortality from ALD• Early data suggest that patients with ALD may be experiencing
increased complications and poor outcomes in COVID-19 era
52© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG
Thank you and stay safe!
53
@AndrewMMoon
© 2020 AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES WWW.AASLD.ORG